Share Name Share Symbol Market Type Share ISIN Share Description
Accsys Technologies Plc LSE:AXS London Ordinary Share GB00BQQFX454 ORD EUR0.05
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -0.27% 73.80 72.20 75.40 73.20 73.00 73.20 39,400 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Construction & Materials 64.8 -6.6 -4.3 - 120

Accsys Technologies Share Discussion Threads

Showing 1551 to 1573 of 1775 messages
Chat Pages: 71  70  69  68  67  66  65  64  63  62  61  60  Older
DateSubjectAuthorDiscuss
18/8/2014
13:52
Accsys Technologies has launched the Accoya Academy - an online learning resource at: www.accoya-academy.com
timberwolf
14/8/2014
17:23
E1.4m cumulative costs in respect of the Diamond Wood dispute up to end-June. Subsequent accrual of costs in respect of arbitration hearing, possible appeal and finalisation of the damages award. Possible award of Diamond Wood legal costs against AXS. Possible E250k damages award against AXS. It's a good job they have lots of cash.
effortless cool
14/8/2014
15:48
You haven't read the announcement properly. The cap you mention is for damages. The tribunal is yet to make an award on costs. PS - you're not Jerry Clegg are you?
gwr7
14/8/2014
13:05
To balance that, their maximum exposure is 250,000 Euro. Additionally, if Diamond Wood now fail to honour their side of the bargain going forward, there's no doubt who will win the next case. Trying to be optimistic, would (no pun intended) Diamond Wood have bothered to fight at all if they really didn't want the license? The only reason for having it and not going into production would be to keep it off the market for reasons of competition. Is anyone saying this is what they are up to? The story continues .... PS - calling PC a tool adds nothing to the debate, IMHO.
ukjerry
14/8/2014
12:22
Not looking forward to the announcement on legal costs which will presumably go in favour of Diamond Wood. Their damages claim was obviously dismissed as absurd but when all's said and done they won, contrary to Clegg's confident belief they wouldn't keep the licence agreement. Looking like a tool seems to run in the family.
gwr7
13/8/2014
07:49
Impressive progress continues.
this_is_me
08/8/2014
09:57
I *really* don't like the idea of AXS investing in licensees' manufacturing operations. It hints to me that management haven't grasped that their core business is an IP business, not a manufacturing one. The model that AXS should constantly have in view is the ARM model. ARM licenses its low-power RISC microprocessor designs to others and takes a few cents from each processor sold. ARM has zero manufacturing costs. It has two main operations: R&D and accounting. ARM's growth has been sensational, as we all know. It hasn't needed cash from investors for donkeys years. Shouldn't AXS be following the same sort of model?
ukjerry
08/8/2014
09:18
I should add , still holding but gone into the red somewhat recently here.....just hoping that it will pick up. Am looking at new business making timber sash windows to order using a new technique, not sure I can afford to use accoya even with benefits as it just adds too much to the price model that I cannot sell through to get back on the bottom line........its a hard sell given there are still victorian pine sash windows still out there and painted, still are OK, not that many but selling the idea of lasting 50-60 years to someone who is only going to live there for 5 years is tricky.
brightontrader
08/8/2014
09:14
The management won't sell because they would lose their jobs, then what for them, what would they do, this way they can keep plugging this technology and gradually burning the cash until its all gone.......
brightontrader
06/8/2014
10:46
Market seems to like the agreement with Solvay. Looking at point 2. Solvay will engage Accsys to carry out targeted marketing activities to develop the Accoya(R) market outside of Europe; I take that to mean that AXS will be paid for such marketing, which is a plus. Looking at point 3: Solvay has granted Accsys the option to invest up to a substantial minority share in both the European project and in any future Accoya(R) production projects I would like a definition of "substantial" maybe 25%? but why not give a figure? It does flag up the need for more cash, so maybe a placing, unless they can borrow their share. Personally I am hoping Solvay will just buy them. :)
stevie blunder
10/7/2014
10:07
I think 1404/5/6 above give a very fair picture overall. I have followed this one since about 10 years ago when I knew Eddie (forget his surname) the then MD. Success was always just around the corner but he burnt out. The problem at the moment seems to me that Solvay and the other licensees are not under any particular pressure to build; this isn't the software industry where speed is essential (except for AXS!). The upside is difficult to quantify and the downside is boredom and negative cash flow. I never bought until this Jan, so am sitting on a acceptable profit. I now have to decide whether to exit and watch with Effortless or hold and hope with brighton and roddie.
123prezzie
04/7/2014
12:46
I sold out of these this morning. I still like the company but struggle to see how it will justify the current market cap over the next couple of years. Some back of the envelope calculations ... - Assume the Arnhem plant operates at full capacity this year and price rises of 10% are achieved vs. 2013/14 average prices. That gives revenue (Accoya plus acetic acid) of E49.1m. Add on, say, E1.5m for licenses takes us to E50.6m. That is 52% growth, vs. 78% this year, and the comparison will be worse if full capacity is not reached. - Assume economies of scale improve the gross margin to 25% (from 23.1%). That gives gross profit of £12.7m. - Assume operating costs of E16.0m (from E15.0m). That gives an operating loss of E3.3m. The bottom line loss will be a bit worse than that and EBITDA will still be negative. - The big problem comes in the 2015/16 year, however. There is no significant additional manufacturing capacity available, so revenue growth will drop off dramatically, say +5% to +10%. EBITDA will probably be about neutral. - Revenue might start motoring again from 2016/17 onwards, if the second factory does not suffer material delays and if other new manufacturing capacity starts to be built, but there is too much hope value in the share for me just now. Plus points are that AXS should not need to raise new funds and that there must be the possibility that it will be taken over, perhaps by Solvay. Good luck to continuing holders; I am going to keep monitoring from the sidelines, for the time being.
effortless cool
03/7/2014
13:19
Sane comment , brightontrader. The truth is that AXS will be a big hit or a dud,---nothing in between. Management have the big picture on their side: growing populations,depleting natural resources, and a trend towards sustainability; that may not be enough. I bought these when they floated , and took profit near their peak, but stupidly bought some back in my ISA. Initially , the shares rose on nothing much more than hype and hope. ( hope springs eternal , but is not an investment strategy ) I agree that we need to see net profits soon.
roddiemac2
03/7/2014
10:26
I know from a technology company these results are fine, talking about burn rates, reduced losses, future deals that look promising etc, and all these things are very much like a software company creating sizzle to keep the share price up or the investment to keep rolling in. However, pouring a little cold water on the results, I created and run 2 successful (small) businesses, one a software company from 89-96 which floated on Nasdaq and latterly CustomWest Shutters which I have just sold to Hillarys, and both these companies produced real profits, had to, as to make real money eventually you need real profits and you cannot exit on dreams alone, people wake up from dreams... I am investing in this until next results then if I cannot see net profits I am out, and I wonder how many others will think this way.
brightontrader
03/7/2014
08:05
Market potential We believe the potential market for Accoya(R) and Tricoya(R) is in excess of 2.5 million m(3) annually. To put this into perspective, during the last year we sold 25,391m(3) , however the total global solid wood market is understood to exceed 400 million m(3) annually. The global wood based panel sector is approximately 290 million m(3) annually.
this_is_me
03/7/2014
07:55
Great results Paul Clegg, Chief Executive commented: "Accsys enjoyed a highly encouraging financial year, delivering progress on all fronts. Our rate of revenue growth demonstrates the traction our products are gaining in the global marketplace. This growth has enabled us to more than double gross profits, helping to reduce our rate of cash burn and maintain a healthy balance sheet with more than adequate financial strength to see us through to profitability in the medium-term.
this_is_me
02/7/2014
19:59
The UK based James Latham Group are a very long established company which, although having been very "traditional" in the past, have certainly moved within recent times and set up an excellent network of branches in the UK over the past few years. Their recent external cladding venture, into Accoya®LathamCLAD, seems to be going very well, together with the "basic" Accoya timber sales. Although I'm only addressing part of the UK market in this post, as I've said in previous posts, I can't see the latest results for Assys being anything short of positive! As for share dealing, I have no problem dealing in AXS shares online with NatWest Stockbrokers.
timberwolf
02/7/2014
18:38
I bought mine online in my Stocktrade ISA
this_is_me
02/7/2014
17:03
I buy them on-line through my Hargreaves Lansdown SIPP..
brightontrader
02/7/2014
16:30
I've been watching Accsys for some time - should have bought sooner! Finally spurred into action by the mention of buoyant Accoya sales in James Latham's annoua results : http://www.investegate.co.uk/latham-james--plc--lthm-/rns/final-results/201406260700065643K/ Had difficulty buying as Alliance Trust won't hold EUR denominated shares in their SIPP - put a few in my Sharecentre SIPP, but they didn't seem able to trade them electronically. And, being listed on Euronext, I don't think they qualify for Business Property Relief for Inherisance Tax. Anyone have any thoughts on this? So, a couple of hurdles for some private investors to have to overcome! Garbetklb
garbetklb
02/7/2014
12:05
Whats the betting for tomorrow result annoucement. Me, 26 cents bid........(bound to be wrong as good news always already discounted.)
brightontrader
01/7/2014
09:24
Edited - Previous news story
timberwolf
30/6/2014
10:26
Yes it is all looking good. I watched these for several years before finally getting in around last Christmas. The potential has always been there but it has taken some time for the conservative building industry to accept the virtues. It looks like things are on the up.
this_is_me
Chat Pages: 71  70  69  68  67  66  65  64  63  62  61  60  Older
ADVFN Advertorial
Your Recent History
LSE
AXS
Accsys Tec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200409 05:31:23